With COVID-19 vaccinations for adolescents aged between 12 to 17 years old underway, we take a look at what concerns parents might still have and some of the misinformation that is going around. We also discuss the planned roll-out of third doses for high-risk groups, as well as what the latest studies tell us about the real-world efficacy of the vaccines that have been used in Malaysia, especially as COVID-19 cases remain relatively high while we inch towards normalcy.

Image credit: Shutterstock

Produced by: Lim Sue Ann

Presented by: Tee Shiao Eek

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  Health Policy,  Diseases & Conditions,  Mental Health,  Healthy Living,  Fitness,  Medical Innovation and Technology,  Science

Tags:  The Bigger Picture,  Health & Living,  COVID-19,  SARS-CoV-2,  Pfizer,  AstraZeneca,  Sinovac,  adolescent vaccination,  vaccine efficacy,  Delta,  booster,  third dose,